In order to further confirm the function of miR-26b as an EphA2 regulator, we next studied the effect of miR-26b in U87 MG glioma cells expressing only low levels of endogenetic EphA 2[27] (Fig. 4B). This evidence concerns the gene EPHA2 and central nervous system cancer.